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Abstract
Background: After menopause, rapid bone mass loss occurs in response to hypoestrogenism. Several studies
suggest that muscle mass and bone mineral density (BMD) are positively associated in postmenopausal women.
Therefore, it may be assumed that postmenopausal low appendicular muscle mass (aMM) can increase BMD loss in
a short period of time.
Objective: The purpose of this study was to assess relationship of aMM with femoral neck BMD in
postmenopausal women.
Methods: Prospective, controlled clinical Trial including 64 women aged 45-70 years, who had not had their last
menstruation for at least one year. Subjects were divided into two groups: low aMM (n = 32), and normal aMM (n-
32). Femoral neck BMD and muscle mass were measured by DXA at baseline and after twelve months. Pairwise
and independent t tests were used for data analysis.
Results: Baseline weight, BMI and muscle mass (total and appendicular) significantly differ between groups (p <
0.05). After twelve months, femoral neck BMD was significantly lower in the group with low aMM, whereas no
significant difference was observed in the group with normal aMM (p < 0.05).
Conclusion: In postmenopausal women, low appendicular muscle mass is associated negatively with femoral neck
BMD in a short period of time.
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Background
During the first years after menopause, rapid bone loss
occurs in response to hypoestrogenism [1]. The decline
in bone mineral density (BMD), and structural integrity
increase the risk of osteoporosis in postmenopausal
women [2]. The most common clinical consequence of
osteoporosis is fracture, especially of the femoral neck,
vertebrae and wrist [2], that lead to functional impair-
ment [3]. In 2005, osteoporosis-related fractures cost 17
billion of dollars to the United States. Hip fractures
accounted for 14% of all fractures and 72% of the costs
[4].
BMD is influenced by several factors. In postmenopau-
sal women, muscle mass (MM) and body weight has
been positively associated with femoral neck BMD [5-9].
Transition into menopause has been associated with MM
reduction [10,11]. High MM loss, together with loss of
muscle strength and/or function is named sarcopenia
[12]. Some investigators have proposed measuring the
muscle mass of the four limbs (appendicular muscle
mass) by DXA (dual-energy X-ray absorptiometry) to
determine low muscle mass [12,13]. Defining muscle
mass index as aMM/height2, a muscle mass index two
standard deviations (2SD) below the mean muscle mass
index of gender-specific reference groups of young adults
indicates low muscle mass [12,13].
Several hypotheses have been built to explain the asso-
ciation of MM on bone mass. Muscle strength gains are
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believed to induce periosteal aposition directly stimulat-
ing, via mechanic strength, osteocyte mechanoreceptors
[14,15]. Additionally, bone and muscle share endocrine
and genetic influences. Muscle has an endocrine function
by producing bioactive molecules that can contribute to
homeostatic regulation of both bone and muscle [14,15].
Bone and muscle also share genetic determinants. There-
fore, the consideration of pleiotropy is an important
aspect in the study of the genetics of osteoporosis and
sarcopenia [14].
Considering muscle mass as an indicator of BMD, It
can be postulated that low muscle mass in postmenopau-
sal women could influence the rate of bone loss. Thus,
the purpose of this study was to assess femoral neck
BMD in postmenopausal women with or without low
aMM.
Methods
Study design and sample selection
A prospective, controlled study with pre- and post-test
assessments was conducted. The study population con-
sisted of women attending the Climacterium & Meno-
pause Service of Botucatu Medical School, São Paulo
State University-UNESP. The study participants were
healthy women aged 45-70 years that had not had their
last menstruation at least 12 months prior to the study,
and FSH (follicle-stimulating hormone) levels greater
than 40 mIU/ml. Exclusion criteria were: (1) hormone
replacement therapy; (2) history of myopathy, neuropa-
thy, or skeletal disease; (3) history of catabolism-elevating
diseases such as cancer, nephropathies and hepatopa-
thies; (4) alcoholism; (5) chronic gastrointestinal disease;
(6) athletes; (7) use of medication known to have meta-
bolic effects on bone and muscle.
Of all the women attending our service, 84 were identi-
fied as potentially eligible. They were informed about the
study objectives and procedures, and asked to provide
their written consent to participate. The study was
approved by the local Committee of Research Ethics.
Initially, all subjects underwent history taking, physical
and gynecological examination and body composition
evaluation, as well as femoral neck BMD measurement
by DXA. Data collected included age, aMM, body fat, %
fat, and femoral neck BMD. After screening was com-
pleted, 64 women were enrolled and allocated into two
groups of 32 easch: 1) low aMM; and, 2) normal aMM
[13]. All 64 subjects were followed up for 12 months with
femoral neck BMD being measured at baseline and at the
end of the study.
Anthropometric assessment
Weight was measured using a platform balance beam
scales (150 kg capacity, 100 g divisions, 0.1 kg precision;
Filizola®, Brasil) with women wearing no shoes and light
clothes. Height was determined using a portable stadi-
ometer (0.1 cm precision; Seca®, Brasil) fixed on wall.
Body mass index (BMI) was classified according to the
system used by the World Health Organization (2002):
< 18.5 kg/m2 = underweight; 18.5 - 24.9 kg/m2 = normal
weight; 25 - 29.9 kg/m2 = overweight; 30.0 - 34.9 kg/m2 =
obese class I; 35.0 to 39.9 kg/m2 = obese class II; ≥
40.0 kg/m2 = obese class III.
Bone mineral density and body composition
Femoral neck BMD and body composition (fat mass and
fat-and bone-free mass) were measured by dual-energy
X-ray absorptiometry (DXA), at baseline and 12 months
later, using a Hologic QDR-2000 densitometer (Holo-
gic®, Waltham, MA, USA). Patients were instructed to
remove metal objects (e.g., snaps, belts, underwire bras,
jewelry) and their shoes and were dressed only in a hos-
pital gown. Patients lay supine with their arms at their
sides and were instructed to remain motionless during
the scan. To minimize interobserver variation, all scans
and tests were performed by the same certified densito-
metry technologist. Intravariation in femoral neck BMD
assessment was 1%. BMD was reported in g/cm2. Body
composition was determined using the manual analysis
software (version 4.76A:1 for BMD and 5.73A). The arm
region was defined as the region extending from the
head of the humerus to the distal tip of the fingers. The
reference point between the head of the humerus and
the scapula was set at the glenoid fossa. The leg region
was defined as the region extending from the inferior
border of the ischial tuberosity to the distal tip of the
toes (Figure 1). The appendicular muscle mass (aMM)
was defined as the summation of the muscle mass (fat-
and bone-free mass) of the four limbs (arms and legs).
Total fat mass and fat-and bone-free mass (tMM) were
defined as the region extending from the shoulders to
the distal tip of the toes. In-house CV on a subsample
of women is, <1.0 - 3.0% for body composition measures
[13,16,17]. Data from our laboratory showed that the
coefficient of variation for body composition measures
was < 1.0% [16]. Measurements of muscle mass by DXA
have been validated [18] against multislice computed
tomography of the legs in 60 persons aged 70-79 (R2 =
0.96, SEE = 0.7 kg)[19] and against MRI of the legs in
101 postmenopausal women similar to our study aged
70.7 ± 6.4 y and their mean BMI was 27.4 ± 5.1 kg/m2
(R2 = 0.82, RMSE = 0.82 kg)[20].
Low aMM was defined as 2 SD below the mean for
gender-specific reference group of young adults as
described by Baumgartner et al.[13]. A muscle mass
index was obtained by dividing aMM (summation of the
muscle mass of the four limbs) by the squared height
(m2). The cut point used was that proposed by Baum-
gartner et al.[13] for women (<5.45 kg/m2)
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Statistical analysis
Statistical analysis was performed using the statistical
software for Windows. Variable distribution was
assessed by the tests of Shapiro-Wilk, Kolmogorov &
Smirnov. A log transformation was applied to the
variables not normally distributed (FSH and E2). Nor-
mally distributed variables were reported as mean and
standard deviations. Differences between groups in base-
line characteristics were tested using a t unpaired test. A
pairwise t test was employed to test the effect of time
Figure 1 Representative DXA images with fat/bone/muscle segmentations illustrated for various body regions.
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(pre vs posttesting). The relationship between baseline
variables and femoral neck BMD changes was deter-
mined by Pearson’s correlation (delta = pretesting value
- posttesting value). Significance level was set at 5%
(p < 0.05).
Results
In this study, group assignment was based on appendi-
cular muscle mass. Thus, as expected, no significant dif-
ferences between groups were observed in baseline
parameters, except weight, BMI, and muscle mass (total
and appendicular) (Table 1). After 12 months, femoral
neck BMD was significantly lower in the group with low
aMM (Low aMM: pre = 0.775 ± 0.095, post = 0.764 ±
0.096 and P = 0.002), whereas the group with normal
muscle mass showed no significant differences (Normal
aMM: pre = 0.812 ± 0.104, post = 0.807 ± 0.098 and
p = 0.368) (Figure 2).
Femoral neck BMD change over 12 months (Δ delta =
posttesting - prettesting) correlated significantly only
with baseline BMI, aMM and aMM/height2 values
(Table 2). BMI showed significant positive correlations
with aMM and aMM/m2 (r = 0.66 and r = 0.73,
respectively).
Discussion
This prospective controlled trial tested the hypothesis
that low aMM is associated with loss of femoral neck
BMD over a short period of time in postmenopausal
women. On the basis of the cut point proposed by
Baumgartner et al [13], femoral neck BMD significantly
decreased in postmenopausal women with low aMM,
but not in those with normal aMM, during a period of
12 months. This finding is in agreement with cross-sec-
tional studies reporting association between muscle
mass and femoral neck BMD [5-7,21].
Our results show that, in relation to time, the effect of
aMM and aMM/height2 (muscle mass index) on femoral
neck BMD is stronger than that on the other anthropo-
metric parameters assessed. Di Monaco et al. (2010),
demonstrated that aMM/height2 had a significant posi-
tive correlation with femoral neck BMD in 313 elderly
women. As a consequence, the odds ratio for osteoporo-
sis in women with low aMM was 1.8 (95%CI = 1.073-
3.018) [5].
The reason why aMM and aMM/height2 correlated
more strongly with femoral neck BMD than total mus-
cle mass may be the fact that DXA-derived measure-
ment includes lean trunk organ tissues, a great amount
of skin and nonfat components in the adipose tissue.
Chen et al. (2007) reported a ratio of MM (DXA):MM
(MRI) was only 1.5 for the leg region, but increased to
2.1 for the total body [20].
Bone has the ability to sense loading-induced defor-
mation and to adapt its structure to the load it receives.
All body movements are produced by coordinated
Table 1 Anthropometric and demographic characteristics of the subjects in the study at baseline
Variables Low aMM (n = 32) Normal aMM (n = 32)
Mean SD Mean SD p value*
Age (years) 57.0 7.4 55.4 7.6 0.397
Time since menopause (years) 7.6 5.8 8.3 5.7 0.618
Weight (kg) 65.9 10.9 76.5 12.9 0.001
BMI (kg/m2) 26.7 3.7 31.7 4.7 <0.001
Total MM (kg) 30.3 3.2 35.9 4.2 <0.001
Appendicular MM (kg) 11.9 1.4 14.6 1.9 <0.001
Appendicular MM/m2 (kg/m2) 4.8 0.5 6.1 0.5 <0.001
Total fat (kg) 26.7 7.8 32.6 9.2 0.007
% fat 45.2 5.4 45.44 5.9 0.874
logFSH 4.2 0.3 4.1 0.3 0.334
logE2 3.0 0.2 3.1 0.2 0.100
SD, standard deviation.
*unpaired t test, significant difference p < 0.05
Figure 2 Effect of twelve months on femoral neck BMD in
women with or without low aMM (mean ± SD). *pairwise t test,
significant difference p < 0.05.
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contractions of the striated muscle, while the associated
muscle work comprises the fundamental source of
mechanical loading to the skeleton positively acting on
bone mass. This is the theoretical support for the asso-
ciation of muscle mass on bone mineral density [22]. In
addition, muscle-released bioactive molecules and
genetic factors can also contribute to regulation of both
bone and muscle [14].
Although the relationship between muscle strength and
muscle mass is not linear, age-related muscle loss may
progressively decrease strength and power (force vs velo-
city), impairing the ability to perform activities of daily
living [12]. This significantly reduces the mechanical load
to the skeleton, contributing for the development of bone
frailty and functional decline at advanced age. Thus,
dual-energy X-ray absorptiometry screening should be
used to identify both BMD and muscle mass in postme-
nopausal women to assess more accurately the risk of
fractures and disability, as suggested by Gentil et al [6].
The beneficial effect of resistance training on muscle
mass, muscle strength and BMD in postmenopausal
women has been well established [23-25]. Besides produ-
cing direct effects on BMD, resistance training has been
associated with decrease in functional disability, as well
as in the occurrence of falls and fractures [25]. Therefore,
resistance training has been widely indicated for the pre-
vention or treatment of sarcopenia and osteoporotic frac-
tures [3].
Weight loss significantly increases postmenopausal
bone loss [8,9,26], but the effects of muscle mass change
on weight-loss-associated bone loss remain unclear. Sir-
ola et al., showed that maintaining muscle strength may
counteract postmenopausal bone loss related to weight
loss [27]. In this study, a significant positive correlation
was observed between BMI and femoral neck BMD.
However, such effect might have been mediated by mus-
cle mass as correlations with body weight and fat were
not significant. Other investigators did not find any asso-
ciation between body fat and BMD either [7,28]. Indeed,
women tend to accumulate visceral fat with menopause.
This appears to involve estrogen-dependent mechanisms
and can be prevented by hormonal replacement therapy
[29]. In postmenopausal women, adipose tissue is a sig-
nificant source of increased proinflammatory cytokines
[29], which are critical mediators of bone metabolism
[30,31]. However, data are not universal [21,32]. Some
authors have suggested that increased fat weight, or total
body weight itself, elevates musculoskeletal dynamic
overloading [33]. On the other hand, others have
reported the independent action of fat mass on BMD
mediated by estrogen, leptin, or insulin [34,35].
Conclusion
In postmenopausal women, low appendicular muscle
mass is associated with femoral neck BMD in a short
period of time. Therefore, our findings support the
hypothesis that maintaining muscle mass, as age
advances, attenuates femoral neck BMD loss.
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